Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 SEK | +2.22% | 0.00% | +53.33% |
Business Summary
Number of employees: 31
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 208 | 100.0 % | 61 | 100.0 % | -70.58% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 208 | 100.0 % | 61 | 100.0 % | -70.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 12-12-31 |
Chief Executive Officer | 71 | 17-05-05 | |
Nicholas Waters
FOU | Founder | 62 | 12-12-31 |
Director of Finance/CFO | 53 | 12-12-31 | |
Peder Svensson
CTO | Chief Tech/Sci/R&D Officer | 62 | 15-12-31 |
Joakim Tedroff
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-12-31 |
Susanna Waters
PRN | Corporate Officer/Principal | 58 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 15-12-31 |
Rein Piir
BRD | Director/Board Member | 66 | 15-12-31 |
Chairman | 66 | 19-03-31 | |
Chief Executive Officer | 71 | 17-05-05 | |
Director/Board Member | 62 | 22-12-31 | |
Veronica Wallin
BRD | Director/Board Member | 38 | 22-12-31 |
Daniel Johnsson
BRD | Director/Board Member | 56 | 22-12-31 |
Director/Board Member | 60 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 79,776 | 0 | 0 | 57.48 % |
Stock B | 1 | 51,788,630 | 29,815,943 ( 57.57 %) | 0 |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.33% | 53.39M | |
+26.47% | 664B | |
+25.51% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.64% | 199B | |
-10.27% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- IRLAB A Stock
- Company IRLAB Therapeutics AB